Table 2

Use of intrapleural streptokinase in empyema thoracis

Reference*
Number of patients
Number of instillations
Complications**

Chin [8]
17
1–10
None
Davies [9]
7
NA
None
Lysy [23]
3
4–10
None
Willsie-Ediger [24]
3
1–10
None
Iaye [25]
9
1–4
Fever (3), chest wall erythema (2)
Alfageme [26]
8
NA
None
Bouros [27]
5
3–10
Fever (1)
Taylor [28]
11
2–6
None
Jerjes-Sanchez [29]
30
2–10
Pleuritic pain (3), Fever (1)
Laisaar [30]
21
2–8
Fever, bleeding
Roupie [31]
16
1–3
Chills and fever (1)
Present Study
12
3–9
None

* Figures in square brackets denote the reference number ** Figures in parenthesis refer to the number of patients that developed the respective complication

Banga et al. BMC Infectious Diseases 2004 4:19   doi:10.1186/1471-2334-4-19